EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer's HYMPAVZI Pediatric Approval Deepens Rare Disease Growth Story
Viral Influencer: How Bill Gates' Billions Shape US Medical Research
Earn $5,000+ Yearly With These 4 Dividend Stocks
Best Pharmaceutical Stocks To Consider - June 9th - Stock Observer
Zai Lab (ZLAB) Gains Approval for Tivdak in Cervical Cancer Treatment
CenterBook Partners LP Sells 320,978 Shares of Pfizer Inc. $PFE - Zolmax
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer
CenterBook Partners LP Lowers Position in Pfizer Inc. $PFE
Pfizer Inc. $PFE Stock Position Lessened by Commonwealth Retirement Investments LLC - Daily Political
Pfizer's Hympavzi Approved for Pediatric Hemophilia Treatment
Pfizer (NYSE:PFE) Stock Price Down 1.5% - What's Next? - Stock Observer
Promising Medical Stocks To Research - June 8th - Stock Observer
Pfizer Target of Unusually Large Options Trading (NYSE:PFE) - Daily Political
Dividend Stocks To Research - June 8th - Daily Political
Not Just a Headache: Year Three of Pfizer's OOO for Migraine Awareness Campaign Aims to Make Migraine a Visible Priority at Work
Pfizer Gets FDA Expanded Hympavzi Approval | Morningstar
US FDA approves Pfizer's bleeding disorder drug for children - Yahoo News Canada
U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Pfizer Inc. $PFE Stock Holdings Increased by O Shaughnessy Asset Management LLC
O Shaughnessy Asset Management LLC Has $65.26 Million Stock Position in Pfizer Inc. $PFE - Zolmax
Pfizer Inc. $PFE Holdings Lifted by Los Angeles Capital Management LLC
Pfizer Inc. $PFE Shares Purchased by Brandywine Global Investment Management LLC
Pfizer Inc. $PFE Shares Purchased by Capital World Investors - Daily Political
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
Pfizer presents results from Phase 2b studies of berobenatide
Top Pharmaceutical Stocks To Watch Today - June 7th - Zolmax
Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough
Pinebridge Investments LLC Acquires New Shares in Pfizer Inc. $PFE - Zolmax
Pfizer Inc. $PFE Shares Bought by Capital International Ltd. CA - Stock Observer
DB&C Advisors LLC Purchases Shares of 37,182 Pfizer Inc. $PFE - Stock Observer
433,331 Shares in Pfizer Inc. $PFE Acquired by Pinebridge Investments LLC - Daily Political
What to know about berobenatide, Pfizer's experimental obesity drug
Pfizer's Berobenatide GLP-1 Obesity Data Might Change The Case For Investing In Pfizer (PFE)
Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial
Vise Technologies Inc. Raises Stock Holdings in Pfizer Inc. $PFE - Zolmax
Vise Technologies Inc. Acquires 63,386 Shares of Pfizer Inc. $PFE
WCG Wealth Advisors LLC Acquires 31,159 Shares of Pfizer Inc. $PFE - Daily Political
Pfizer CEO Albert Bourla reflects on leadership through Covid successes and post-pandemic challenges
Johnson & Johnson (JNJ) Gets a Buy from Guggenheim
Pharmaceutical Stocks To Consider - June 5th - Stock Observer
Pfizer (NYSE:PFE) Trading Up 1.4% - What's Next? - Daily Political
Prudential PLC Sells 88,665 Shares of Pfizer Inc. $PFE
How New Multi‑Tumor Oncology Data At Pfizer (PFE) Has Changed Its Investment Story
US companies disclose huge Irish tax payments
Pfizer's integrin β6 ADC advances intravesical therapy for NMIBC | BioWorld
New US corporation tax regulations could put Ireland in Trump's crosshairs
UBS Remains a Buy on Olema Pharmaceuticals (OLMA)
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA
Pfizer (NYSE:PFE) Trading 1.4% Higher - What's Next?
Pfizer (PFE) Partners with Chai Discovery for AI-Driven Drug Development
Pfizer strikes $10.5 billion oncology deal with Chinese biotech
Natixis Advisors LLC Raises Position in Pfizer Inc. $PFE
One Capital Management LLC Cuts Position in Pfizer Inc. $PFE
Pfizer patents new PI3Kα mutant inhibitors | BioWorld
Pfizer (PFE) Valuation Check After Recent Share Price Pressure And Rebuilding Momentum
Cigarette smoking, e-cigarette use, and hypertension: a population-based cross-sectional study
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
Top 5 High-Yield Dividend Stocks for Income Investors in 2026
Pfizer vs Merck: Chasing High Yield vs Higher Returns
Bank of New York Mellon Corp Raises Stake in Pfizer Inc. $PFE
Celcuity (CELC) Shares Plunge Over 20% Following Phase 3 Trial Data
Is Pfizer Inc. (PFE) Expanding Its Cancer Pipeline Through a Landmark Innovent Partnership?
Why Pfizer's Current Price May Be Too Cheap to Ignore
Pfizer CEO Albert Bourla on the company's obesity drug pipeline
Pfizer CEO Albert Bourla on the company's oncology focus
Pfizer's ASCO 2026 Cancer Results Test Oncology Focus And Valuation Story
Pfizer Unveils Innovative Cancer Treatment Elranatamab in India, ETPharma
Work or vacation? Why global health giants are flocking to Hainan - Chinadaily.com.cn
Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort
Pfizer (NYSE:PFE) Stock Price Down 2.1% - Here's Why
Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax
Company Website: https://www.pfizer.com NEW YORK -- (Busin
Pfizer Oncology Deal And Lung Cancer Data Reshape Valuation Debate
Centene Corporation (CNC) and Pfizer (PFE) Stand Out in Valuatio
3 Cash-Producing Stocks Worth Your Attention
Pfizer Inc. $PFE Shares Acquired by Nomura Asset Management Co. Ltd.
Nomura Asset Management Co. Ltd. Has $52.42 Million Position in Pfizer Inc. $PFE - Daily Political
Assessing Celcuity (CELC) Valuation As Investor Optimism And Conflicting Fair Value Views Intensify
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Innovent Biologics and Pfizer ink $10.5 B deal to develop innovative oncology medicines
Evaluating the Clinical and Humanistic Impact of a Self-Care and Minor Ailment Service (MAS)
What To Buy If Not AI? Top Goldman Trader Finds 'Scarcity' Elsewhere
Is Pfizer Stock a "Value Trap" or a Generational Opportunity? - AOL
Pfizer (PFE) Reports Promising Results from Breakwater Trial
Cohort 3 analysis from the Phase 3 BREAKWATER study showed a
Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri
11 Most Undervalued Pharma Stocks to Invest In
Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi
PFIZER News
Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain
Phased Economic Pressure on Iran: A Strategy to Reopen the Strait of Hormuz
US Strikes Iran Again: Military Pressure Falls Short of Diplomatic Breakthrough
Hormuz Strait Reopens: Shifting Oil Market Dynamics and OPEC's Weakening Grip
US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets
CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts
Latest news
Show moreUS Labor Statistics Nominee Affirms Data Integrity Amid Funding and Participation Challenges
As SpaceX, OpenAI, and Anthropic Approach IPOs: New Capital Flows and Sector Reshaping
UAE-Iran High-Level Talks Signal Shift Towards Regional De-escalation Amidst Tensions
SK Hynix Pivots NAND Competition to Material Innovation with 375-Layer Chip
